The World’s First “Recombinant Anthrax Vaccine”: GC Biopharma applies for MFDS Approval
GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine jointly developed by…
Where health news comes full circle!